Eyenovia plans to submit for U.S. device regulatory approval in Q4 of this year, marking a key step toward commercialization
Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device
Seeking Alpha / 2 hours from now 2 Views
Eyenovia plans to submit for U.S. device regulatory approval in Q4 of this year, marking a key step toward commercialization
Comments